CWA Asset Management Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.98M Buy
498,643
+208,277
+72% +$870K 0.06% 290
2026
Q2
$1.22M Buy
+290,366
New +$1.12M 0.04% 367

Other funds holding IRWD

CWA Asset Management Group's IRWD Position: Q3 2026 in Review

CWA Asset Management Group increased its Ironwood Pharmaceuticals (IRWD) stake by 72% in Q3 2026, buying an estimated $870K and bringing the position to 498,643 shares worth $1.98M. The position accounts for 0.06% of the portfolio, ranked #290.

CWA Asset Management Group first reported a position in IRWD in Q2 2026 and has held it in 2 quarters since. 234 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

  • CWA Asset Management Group held 498,643 shares of Ironwood Pharmaceuticals worth $1.98M as of Q3 2026.
  • CWA Asset Management Group bought 208,277 Ironwood Pharmaceuticals shares in Q3 2026, an estimated $870K.
  • Ironwood Pharmaceuticals made up 0.06% of CWA Asset Management Group's portfolio in Q3 2026, its #290 holding.
  • CWA Asset Management Group first reported a position in Ironwood Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • 234 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on CWA Asset Management Group's 13F filing for Q3 2026, filed 19 Oct 2026.